 |
8 Diseases |  |
0 Trials |
|
0 Trials |  |
2 News |  |
- recombinant human Complement Receptor Type 1 (CDX-1135) / Celldex
Trial termination: Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease (clinicaltrials.gov) - Mar 5, 2014
P1, N=1, Terminated, Sponsor: Celldex Therapeutics
Recruiting --> Terminated; Portfolio prioritization due to slow enrollment and variable spectrum of potential complement abnormalities in DDD patients.
- recombinant human Complement Receptor Type 1 (CDX-1135) / Celldex
New P1 trial: Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease (clinicaltrials.gov) - Feb 13, 2013
P1, N=1, Terminated, Sponsor: Celldex Therapeutics